Gadolinium-containing contrast agents: new advice to minimise the risk of nephrogenic systemic fibrosis

Gadolinium-containing contrast agents are associated with a varying degree of risk of nephrogenic systemic fibrosis. See advice below to minimise risk in the following vulnerable groups: patients with renal impairment; patients in the perioperative liver transplantation period; infants, neonates, and the elderly; and women who are pregnant or breastfeeding. High-risk gadolinium-containing contrast agents are contraindicated in patients with severe renal impairment, patients in the perioperative liver-transplantation period, and in neonates